CVS Caremark to kick AbbVie's Humira off some formularies in favor of cheaper biosimilars
Fierce Pharma
JANUARY 4, 2024
This year, CVS Health plans to employ the classic "out with the old, in with the new" mantra when it comes to AbbVie’s Humira. | The changes to major commercial formularies will take effect April 1 and favor Humira biosimilar options over the branded drug as part of CVS' efforts to ramp up U.S.
249 
Let's personalize your content